HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 2077-2084

  Nishimoto, Arata ^a   Kugimiya, Naruji ^a   Hosoyama, Tohru ^a   Enoki, Tadahiko ^a   Li, Tao Sheng ^b   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Anti apoptosis; Glucose deprivation; HIF 1 ; STAT3; TCF4

Indexed keywords

DOXORUBICIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BCL 2; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; HIF1A PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; TCF4 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL SURVIVAL; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DNA BINDING; GENE TARGETING; GLUCOSE DEPRIVATION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ENZYME ACTIVATION; PROTEIN DNA BINDING; COLON TUMOR; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLUCOSE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 84899584147     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2367     Document Type: Article

References (30)

1. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
2. Hirayama A, Kami K, Sugimoto M, et al: Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69: 4918-4925, 2009.
3. Zhou J, Schmid T, Schnitzer S and Brüne B: Tumor hypoxia and cancer progression. Cancer Lett 237: 10-21, 2006.
4. Cummins EP and Taylor CT: Hypoxia-responsive transcription factors. Eur J Physiol 450: 363-371, 2005.
5. Selvendiran K, Bratasz A, Kuppusamy ML, et al: Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer 125: 2198-2204, 2009.
6. Oh M-K, Park H-J, Kim N-H, et al: Hypoxia-inducible factor-1α enhances haptoglobin gene expression by improving binding of STAT3 to the promoter. J Biol Chem 286: 8857-8865, 2011.
7. Ledoux S, Yang R, Friedlander G and Laouari D: Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response. Cancer Res 63: 7284-7290, 2003.
8. Cui H, Darmanin S, Natsuisaka M, et al: Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin. Cancer Res 67: 3345-3355, 2007.
9. Duan Z, Foster R, Bell DA, et al: Signal transducer and activator of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 12: 5055-5063, 2006.
10. Liu L, Ning X, Sun L, et al: Hypoxia-inducible factor-1α contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99: 121-128, 2008.
11. Kendziorra E, Ahlborn K, Spitzner M, et al: Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis 32: 1824-1831, 2011.
12. Lee AS: GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 67: 3496-3499, 2007.
13. Mathieu J, Zhang Z, Zhou W, et al: HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 71: 4640-4652, 2011.
14. Real PJ, Sierra A, Juan A, et al: Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 21: 7611-7618, 2002.
15. Forsythe JA, Jiang BH, Iyer NV, et al: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996.
16. Niu G, Wright KL, Huang M, et al: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008, 2002.
17. Hwang I, Kim J and Jeing S: β-catenin and peroxisome proliferator-activated receptor-δ coordinate dynamic chromatin loops for the transcription of vascular endothelial growth factor A gene in colon cancer cells. J Biol Chem 287: 41364-41373, 2012.
18. Rodda DJ, Chew J-L, Lim L-H, et al: Transcriptional regulation of Nanog by OCT4 and SOX2. J Biol Chem 280: 24731-24737, 2005.
19. Izuishi K, Kato K, Ogura T, et al: Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res 60: 6201-6207, 2000.
20. Korinek V, Barker N, Morin PJ, et al: Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787, 1997.
21. Reed JC: Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 7: 541-546, 1995.
22. Samuel S, Fan F, Dang LH, et al: Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells. Oncogene 30: 1205-1212, 2011.
23. Loh Y-H, Ng J-H and Ng H-H: Molecular framework underlying pluripotency. Cell Cycle 7: 885-891, 2008.
24. Chiou S, Wang M-L, Chou Y-T, et al: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70: 10433-10444, 2010.
25. Vaiopoulos AG, Kostakis ID, Koutsilieris M and Papavassiliou AG: Concise review: colorectal cancer stem cells. Stem Cells 30: 363-371, 2012.
26. Kim J-W and Dang CV: Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66: 8927-8930, 2006.
27. Kaelin WG Jr and Thompson CB: Clues from cell metabolism. Nature 465: 562-564, 2010.
28. Liu X-W, Su Y, Zhu H, et al: HIF-1α-dependent autophagy protects Hela cells from fenretinide (4-HPR)-induced apoptosis in hypoxia. Pharmacol Res 62: 416-425, 2010.
29. Jung JE, Lee H-G, Cho I-H, et al: STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J 19: 1296-1298, 2005.
30. Xu Q, Briggs J, Park S, et al: Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24: 5552-5560, 2005.